Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Wilbert S. Aronow. (2020) Managing the elderly patient with hypertension: current strategies, challenges, and considerations. Expert Review of Cardiovascular Therapy 18:2, pages 117-125.
Read now
Read now
Srikanth Yandrapalli, Suman Pal, Christopher Nabors & Wilbert S. Aronow. (2018) Drug treatment of hypertension in older patients with diabetes mellitus. Expert Opinion on Pharmacotherapy 19:7, pages 633-642.
Read now
Read now
Yogita Rochlani, Mohammed Hasan Khan, Maciej Banach & Wilbert S. Aronow. (2017) Are two drugs better than one? A review of combination therapies for hypertension. Expert Opinion on Pharmacotherapy 18:4, pages 377-386.
Read now
Read now
Emily McNicholas & Ahmed H. Abdelhafiz. (2017) Diabetes management in older people: a focus on cardiovascular risk reduction. Postgraduate Medicine 129:2, pages 169-177.
Read now
Read now
Wilbert S Aronow. (2016) Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines. Expert Opinion on Pharmacotherapy 17:2, pages 205-215.
Read now
Read now
Gastone Leonetti & Colin G Egan. (2012) Use of carvedilol in hypertension: an update. Vascular Health and Risk Management 8, pages 307-322.
Read now
Read now
Wilbert S Aronow. (2012) Treatment of hypercholesterolemia and hypertension in diabetics with coronary artery disease. Clinical Lipidology 7:6, pages 689-695.
Read now
Read now
Wilbert S. Aronow. (2012) Current Approaches to the Treatment of Hypertension in Older Persons. Postgraduate Medicine 124:1, pages 50-59.
Read now
Read now
Articles from other publishers (34)
Rasha M. S. M. Mohamed, Enssaf Ahmad Ahmad, Bothina H. F. Omran, Amr T. Sakr, Islam A. A. E.-H. Ibrahim, Mona F. Mahmoud & Mostafa E. El-Naggar. (2022) Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor. Naunyn-Schmiedeberg's Archives of Pharmacology 395:12, pages 1537-1548.
Crossref
Crossref
Oliver William Scott, Sandar Tin Tin, J. Mark Elwood, Alana Cavadino, Laurel A. Habel, Marion Kuper-Hommel, Ian Campbell & Ross Lawrenson. (2022) Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study. Breast Cancer Research and Treatment 193:1, pages 225-235.
Crossref
Crossref
Ying Guo, Hui He, Haishuang Huang, Jingxuan Qiu, Jiaming Han, Shen Hu, Haoyou Liu, Yue Zhao & Peng Wang. (2021)
Solubility Behavior of
l
-Homophenylalanine Ethyl Ester Hydrochloride in 12 Individual Solvents from 283.15 to 323.15 K
. Journal of Chemical & Engineering Data 66:9, pages 3629-3636.
Crossref
Crossref
Wilbert S. Aronow. (2020) Managing Hypertension in the elderly: What’s new?. American Journal of Preventive Cardiology 1, pages 100001.
Crossref
Crossref
Wilbert S. Aronow. (2020) Approaches for the Management of Resistant Hypertension in 2020. Current Hypertension Reports 22:1.
Crossref
Crossref
Wilbert S. Aronow. (2019) Implications of the New 2017 American College of Cardiology/American Heart Association Guidelines for Hypertension. Minerva Cardioangiologica 67:5.
Crossref
Crossref
Wilbert S. Aronow & William H. Frishman. (2018) Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines. Drugs 78:5, pages 567-576.
Crossref
Crossref
Wilbert S. Aronow & William H. Frishman. (2018) Implications of the New National Guidelines for Hypertension. Cardiology in Review 26:2, pages 55-61.
Crossref
Crossref
Neema Kumari, Himanshu Gaur & Anamika Bhargava. (2018) Cardiac voltage gated calcium channels and their regulation by β-adrenergic signaling. Life Sciences 194, pages 139-149.
Crossref
Crossref
Yogita Rochlani, Mohammed Hasan Khan & Wilbert S. Aronow. (2017) Managing Hypertension in Patients Aged 75 Years and Older. Current Hypertension Reports 19:11.
Crossref
Crossref
Wilbert S. Aronow. (2017) Managing Hypertension in the Elderly: What is Different, What is the Same?. Current Cardiovascular Risk Reports 11:8.
Crossref
Crossref
Wilbert S. Aronow. (2017) Managing Hypertension in the Elderly: What is Different, What is the Same?. Current Hypertension Reports 19:8.
Crossref
Crossref
Omolara B Sanni, Úna C Mc Menamin, Chris R Cardwell, Linda Sharp, Liam J Murray & Helen G Coleman. (2017) Commonly used medications and endometrial cancer survival: a population-based cohort study. British Journal of Cancer 117:3, pages 432-438.
Crossref
Crossref
Chris R. Cardwell, Anton Pottegård, Evelien Vaes, Hans Garmo, Liam J. Murray, Chris Brown, Pauline A. J. Vissers, Michael O’Rorke, Kala Visvanathan, Deirdre Cronin-Fenton, Harlinde De Schutter, Mats Lambe, Des G. Powe, Myrthe P. P. van Herk-Sukel, Anna Gavin, Søren Friis, Linda Sharp & Kathleen Bennett. (2016) Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts. Breast Cancer Research 18:1.
Crossref
Crossref
Kengo Takahashi, Kyoichi Kaira, Akira Shimizu, Taisuke Sato, Norifumi Takahashi, Hiroomi Ogawa, Daisuke Yoshinari, Takehiko Yokobori, Takayuki Asao, Izumi Takeyoshi & Tetsunari Oyama. (2016) Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma. Tumor Biology 37:10, pages 13885-13892.
Crossref
Crossref
Akira Shimizu, Kyoichi Kaira, Keita Mori, Madoka Kato, Kimihiro Shimizu, Masahito Yasuda, Ayumi Takahashi, Tetsunari Oyama, Takayuki Asao & Osamu Ishikawa. (2015) Prognostic significance of β2-adrenergic receptor expression in malignant melanoma. Tumor Biology 37:5, pages 5971-5978.
Crossref
Crossref
Wilbert S. Aronow. (2016) Optimal Blood Pressure Goals in Patients With Hypertension at High Risk for Cardiovascular Events. American Journal of Therapeutics 23:1, pages e218-e223.
Crossref
Crossref
Wilbert S. Aronow & William H. Frishman. 2016. Translational Research in Coronary Artery Disease. Translational Research in Coronary Artery Disease
167
177
.
S Hashemi, J Salma, S Wales & JC McDermott. (2015) Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers. Cell Death Discovery 1:1.
Crossref
Crossref
Wilbert S. Aronow. (2015) Blood Pressure Goals and Targets in the Elderly. Current Treatment Options in Cardiovascular Medicine 17:7.
Crossref
Crossref
Wilbert S. Aronow. (2015) Treating hypertension and prehypertension in older people: When, whom and how. Maturitas 80:1, pages 31-36.
Crossref
Crossref
Wilbert S. Aronow. (2014) What Should the Systolic Blood Pressure Treatment Goal Be in Patients Aged 60 Years and Older with Hypertension?. Current Geriatrics Reports 3:4, pages 299-305.
Crossref
Crossref
Wilbert S Aronow. (2014) Eighth Joint National Committee guidelines. Future Cardiology 10:4, pages 461-463.
Crossref
Crossref
C. McCourt, H.G. Coleman, L.J. Murray, M.M. Cantwell, O. Dolan, D.G. Powe & C.R. Cardwell. (2014) Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study. British Journal of Dermatology 170:4, pages 930-938.
Crossref
Crossref
Chris R Cardwell, Helen G Coleman, Liam J Murray, Frank Entschladen & Des G Powe. (2013) Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort. International Journal of Epidemiology 42:6, pages 1852-1861.
Crossref
Crossref
Virginie Bolduc, Nathalie Thorin-Trescases & Eric Thorin. (2013) Endothelium-dependent control of cerebrovascular functions through age: exercise for healthy cerebrovascular aging. American Journal of Physiology-Heart and Circulatory Physiology 305:5, pages H620-H633.
Crossref
Crossref
A. Sapir, A. Hariton Shalev, N. Skalka, A. Bronshtein & M. Altstein. (2013) Development of an enzyme-linked immunosorbent assay and a beta-1 adrenergic receptor-based assay for monitoring the drug atenolol. Environmental Toxicology and Chemistry 32:3, pages 585-593.
Crossref
Crossref
Ramiro J. Zepeda, Rodrigo Castillo, Ramón Rodrigo, Juan C. Prieto, Ivonne Aramburu, Solange Brugere, Katia Galdames, Viviana Noriega & Hugo F. Miranda. (2012) Effect of Carvedilol and Nebivolol on Oxidative Stress‐related Parameters and Endothelial Function in Patients with Essential Hypertension. Basic & Clinical Pharmacology & Toxicology 111:5, pages 309-316.
Crossref
Crossref
Luc Poirier & Yves Lacourcière. (2012) The Evolving Role of β-Adrenergic Receptor Blockers in Managing Hypertension. Canadian Journal of Cardiology 28:3, pages 334-340.
Crossref
Crossref
Cristiana Vitale, Giuseppe Marazzi, Ferdinando Iellamo, Ilaria Spoletini, Valentina Dall'Armi, Massimo Fini & Maurizio Volterrani. (2012) Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: The NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study. International Journal of Cardiology 155:2, pages 279-284.
Crossref
Crossref
Jillian G. Baker, Philip Kemp, Julie March, Laurice Fretwell, Stephen J. Hill & Sheila M. Gardiner. (2011)
Predicting
in vivo
cardiovascular properties of β‐blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses
. The FASEB Journal 25:12, pages 4486-4497.
Crossref
Crossref
Wilbert S. Aronow. (2011) Office Management of Hypertension in Older Persons. The American Journal of Medicine 124:6, pages 498-500.
Crossref
Crossref
Jillian G. Baker, Stephen J. Hill & Roger J. Summers. (2011) Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling. Trends in Pharmacological Sciences 32:4, pages 227-234.
Crossref
Crossref
Michael J.A. Walker. (2011) The major impacts of James Black's drug discoveries on medicine and pharmacology. Trends in Pharmacological Sciences 32:4, pages 183-188.
Crossref
Crossref